 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2018 |
$19.02 |
$19.72 |
$18.54 |
$19.06 |
7.80K | | 04/19/2018 |
$19.00 |
$19.00 |
$18.68 |
$18.94 |
3.40K | | 04/20/2018 |
$18.70 |
$19.25 |
$18.50 |
$18.75 |
10.70K | | 04/23/2018 |
$18.59 |
$20.40 |
$18.59 |
$19.21 |
11.10K | | 04/24/2018 |
$18.92 |
$19.94 |
$18.85 |
$18.99 |
20.90K |
|
|
| Acer Therapeutics is a biopharmaceutical company developing a personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis as well as other autoimmune diseases such as neuromyelitis optica (NMO). Co. has been developing OPX-212 as an autologous T-cell immunotherapy for the treatment of NMO. NMO is an autoimmune disorder in which immune system cells and antibodies attack astrocytes causing to the secondary destruction of nerve cells (axons) in the optic nerves and the spinal cord. OPX-212 is specifically tailored to each patient's immune response to a protein, aquaporin-4 expressed by astrocytes, which is the targeted antigen in NMO. |
|
|
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on April 18, 2018, ACER opened at $19.02, traded as high as $19.72 and as low as $18.54, and closed at $19.06. Trading volume was a total of 7.80K shares. On April 19, 2018, ACER opened at $19.00, traded as high as $19.00 and as low as $18.68, and closed at $18.94. Trading volume was a total of 3.40K shares. On April 20, 2018, ACER opened at $18.70, traded as high as $19.25 and as low as $18.50, and closed at $18.75. Trading volume was a total of 10.70K shares. On April 23, 2018, ACER opened at $18.59, traded as high as $20.40 and as low as $18.59, and closed at $19.21. Trading volume was a total of 11.10K shares. On April 24, 2018, ACER opened at $18.92, traded as high as $19.94 and as low as $18.85, and closed at $18.99. Trading volume was a total of 20.90K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/25/2008 |
|
| End date: |
04/24/2018 |
|
| Start price/share: |
$11.25 |
|
| End price/share: |
$18.99 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
68.80% |
|
| Average Annual Total Return: |
5.37% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$16,874.54 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2018 | $19.06 | | 04/19/2018 | $18.94 | | 04/20/2018 | $18.75 | | 04/23/2018 | $19.21 | | 04/24/2018 | $18.99 |
|
|
